Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:2020

Hepatitis C Global Clinical Trials Review, Q2, 2011

Hepatitis C Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Hepatitis C Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hepatitis C Global Clinical
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Hepatitis C Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, Q2, 2011" provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Hepatitis C 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Hepatitis C 21
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Hepatitis C Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Merck & Co., Inc. 32
Clinical Trial Overview of Merck & Co., Inc. 32
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Abbott Laboratories 43
Clinical Trial Overview of Abbott Laboratories 43
Vertex Pharmaceuticals Incorporated 45
Clinical Trial Overview of Vertex Pharmaceuticals Incorporated 45
Idenix Pharmaceuticals, Inc. 46
Clinical Trial Overview of Idenix Pharmaceuticals, Inc. 46
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Gilead Sciences, Inc. 49
Clinical Trial Overview of Gilead Sciences, Inc. 49
GlaxoSmithKline plc 50
Clinical Trial Overview of GlaxoSmithKline plc 50
Tibotec Pharmaceuticals Ltd. 51
Clinical Trial Overview of Tibotec Pharmaceuticals Ltd. 51
Boehringer Ingelheim GmbH 52
Clinical Trial Overview of Boehringer Ingelheim GmbH 52
Romark Laboratories, L.C. 53
Clinical Trial Overview of Romark Laboratories, L.C. 53
Human Genome Sciences, Inc. 54
Clinical Trial Overview of Human Genome Sciences, Inc. 54
Valeant Pharmaceuticals International, Inc. 55
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 55
Hoffmann-La Roche Inc. 56
Clinical Trial Overview of Hoffmann-La Roche Inc. 56
Mitsubishi Tanabe Pharma Corporation 57
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 57
UMC Utrecht 58
Clinical Trial Overview of UMC Utrecht 58
SciClone Pharmaceuticals, Inc. 59
Clinical Trial Overview of SciClone Pharmaceuticals, Inc. 59
Clinical Trial Overview of Top Universities / Institutes / Hospitals 60
The National Institute of Allergy and Infectious Diseases 60
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 60
The National Institute of Diabetes and Digestive and Kidney Diseases 62
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 62
French National Agency for Research on AIDS and Viral Hepatitis 63
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 63
University Health Network 64
Clinical Trial Overview of University Health Network 64
U.S. Department of Veterans Affairs 65
Clinical Trial Overview of U.S. Department of Veterans Affairs 65
Kaohsiung Medical University Chung-Ho Memorial Hospital 66
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital 66
University of California, San Francisco 67
Clinical Trial Overview of University of California, San Francisco 67
Hadassah Medical Organization 68
Clinical Trial Overview of Hadassah Medical Organization 68
Okayama University 69
Clinical Trial Overview of Okayama University 69
University of Pittsburgh 70
Clinical Trial Overview of University of Pittsburgh 70
Kyoto University 71
Clinical Trial Overview of Kyoto University 71
Rockefeller University 72
Clinical Trial Overview of Rockefeller University 72
McGill University Health Center 73
Clinical Trial Overview of McGill University Health Center 73
Ziv Medical Center 74
Clinical Trial Overview of Ziv Medical Center 74
Cornell University 75
Clinical Trial Overview of Cornell University 75
Hospital Clinic de Barcelona 76
Clinical Trial Overview of Hospital Clinic de Barcelona 76
The University of Tokyo 77
Clinical Trial Overview of The University of Tokyo 77
Mount Sinai School of Medicine 78
Clinical Trial Overview of Mount Sinai School of Medicine 78
Mayo Clinic 79
Clinical Trial Overview of Mayo Clinic 79
Saitama Medical University 80
Clinical Trial Overview of Saitama Medical University 80
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84




...